Anoro Ellipta (umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for chronic obstructive pulmonary disease (COPD). As with other drugs, Anoro ...

Umeclidinium 62.5mcg, vilanterol 25mcg; per ­inhalation; dry pwd for oral inhalation. Umeclidinium is a long-acting muscarinic antagonist, which is often referred to as an anticholinergic. It has ...

Its new use is based on an analysis of the phase 3 IMPACT study, which showed Trelegy was better than GSK’s already approved combinations Relvar/Breo Ellipta and Anoro Ellipta. Trelegy is also ...

Innoviva is entitled to receive royalties from GSK on sales of RELVAR ® /BREO ® ELLIPTA ® and ANORO ® ELLIPTA ®. Innoviva’s other innovative healthcare assets include infectious disease and critical ...